Fridays @ 7:30 PM EST
People have underestimated how strong the U.S. economy can be: Rick Rieder
BlackRock Global Fixed Income CIO Rick Rieder provides insight on the global economy on 'Barron's Roundtable.'
Why is September a terrible month for stocks?
Panelists Ben Levisohn, Carleton English and Jack Hough discuss the stock market, the threat of China and inflation on 'Barron's Roundtable.'
How can Warner Bros recover financially?
Jack Otter and ‘Barron’s Roundtable’ discuss the challenges still facing Warner Bros. after merge with Discovery.
These are the 3 things investors need to be thinking about right now
'Barron's Roundtable' panelists discuss the new iPhone, interest rates and more.
US is at an 'incredibility elevated' number of open jobs: Sébastien Page
T. Rowe Price's Sébastien Page reacts to the August jobs report on 'Barron's Roundtable.'
Jerome Powell's 'hawkish' speech reminds me of a 'Seinfeld' episode: Ed Yardeni
Yardeni Research president Ed Yardeni reacts to the Federal Reserve's inflation fight and potentially additional rate hikes on 'Barron's Roundtable.'
What went wrong with Monster's Q2 earnings?
Barron's stock pick writer Jacob Sonenshine provides insight on the energy drink company's success on 'Barron's Roundtable.'
Powell says the Fed will be data-dependent: Ben Levisohn
Panelists Ben Levisohn, Al Root and Andrew Bary provide insight on the Federal Reserve's moves on 'Barron's Roundtable.'
Finance expert breaks down what to look for in promising AI stocks
NYU Stern School of Business finance professor Aswath Damodaran breaks down the evaluation of Nvidia stock and where it is likely headed on 'Barron's Roundtable.'
Earnings growth stinks: Jack Hough
Panelists Jack Hough, Carleton English and Elizabeth O'Brien break down stock market performance on 'Barron's Roundtable.'
Oppenheimer effect gifts IMAX best July ever: 'No greater experience,' says CEO Richard Gelfond
IMAX CEO Richard Gelfond reacts to Oppenheimer's success and the impact blockbusters have on the movie industry on 'Barron's Roundtable.'
Could new obesity drugs have benefits other than weight loss?
Jack Hough and the panel discuss a new drug aimed at tackling obesity and the possible other benefits the drug may have on ‘Barron’s Roundtable.’
Barron’s top three things to know about the markets this week
Jack Hough and the panel discuss what investors should know about the week on ‘Barron’s Roundtable.’
How the IMAX experience is leveraging the cinema revival
IMAX CEO Richard Gelfond reacts to Oppenheimer's success and the impact blockbusters have on the movie industry on 'Barron's Roundtable.'
GDP is above every forecaster: Jeremy Siegel
Wharton Finance Professor Jeremy Siegel discusses the Fed’s fight against inflation on ‘Barron’s Roundtable.’
Economic outlook: Investors hoping for a Goldilocks economy
'Barron's Roundtable' panelists react to July's jobs report and give their economic outlook.
Are flying taxis becoming a reality?
Joby Aviation founder and CEO JoeBen Bevirt has the latest on flying car developments on 'Barron's Roundtable.'
Are the dog days over for Disney?
Senior writer Nicholas Jasinski joins 'Barron's Roundtable' to make the case for why now is the time to buy Disney stock amid positive catalysts.
‘Barron’s Roundtable’ recaps the stock market news of the week
Jack Otter and panelists highlight the major takeaways from the past week in the stock market on ‘Barron’s Roundtable.’
Annuity sales are back for investors
Jack Otter and panelists discuss why annuity sales have grown on ‘Barron’s Roundtable.’